Search Results
Jun 29, 2026, 04:26 ET FS KKR Capital Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FSK
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 29, 2026, 04:25 ET Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 29, 2026, 04:24 ET Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 29, 2026, 04:23 ET Graphic Packaging Holding Company Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GPK
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 29, 2026, 04:21 ET POET Technologies Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - POET
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 29, 2026, 04:19 ET SES AI Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SES
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 29, 2026, 03:41 ET Futu Holdings Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FUTU
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 29, 2026, 03:23 ET Sportradar Group AG Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SRAD
release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email:
More news about: DJS Law Group LLP
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
ABVRRTI81580.AbbVie. Data on file ABVRRTI81456.Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177-188, quiz 189-190.Pratt CH, King LE, Messenger AG, Christiano
More news about: AbbVie
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
ABVRRTI81580.AbbVie. Data on file ABVRRTI81456.Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177-188, quiz 189-190.Pratt CH, King LE, Messenger AG, Christiano
More news about: AbbVie
Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
statement from the International Vitiligo Task Force part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol. 2023;37(11):2173-2184. doi:10.1111/jdv.19451Seneschal J, Boniface K. Vitiligo: Current therapies and future treatments. Dermatol Pract Concept. 2023;13(4S2):e2023313S.
More news about: AbbVie
Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
statement from the International Vitiligo Task Force part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol. 2023;37(11):2173-2184. doi:10.1111/jdv.19451Seneschal J, Boniface K. Vitiligo: Current therapies and future treatments. Dermatol Pract Concept. 2023;13(4S2):e2023313S.
More news about: AbbVie
Jun 28, 2026, 20:40 ET Toby Neugebauer to Host Town Hall Webinar Directly with Analysts Tuesday, June 30 as Shareholders are Owed Answers; If Perrys Can't Accept Invitation, Neugebauer Pleased to Invite Fermi Co-President and COO, Jacobo Ortiz, to Answer for the Company
content:https://www.prnewswire.co.uk/news-releases/toby-neugebauer-to-host-town-hall-webinar-directly-with-analysts-tuesday-june-30-as-shareholders-are-owed-answers-if-perrys-cant-accept-invitation-neugebauer-pleased-to-invite-fermi-co-president-and-coo-jacobo-ortiz-to-answe-302812772.html
More news about: Toby Neugebauer
Jun 28, 2026, 15:35 ET NEW SHUTTLE CONNECTS VISITORS TO NORTH SHORE BUSINESSES STILL FEELING THE ECONOMIC IMPACT OF MARCH STORMS
family, and every local family carries a story with the power to transform how visitors come to know Hawaiʻi." — Dr. Aaron J. Salā, president & CEO, Hawaiʻi Visitors and Convention BureauABOUT HAWAIIAN COUNCILThe Hawaiian Council
More news about: Hawaii Visitors and Convention Bureau
Jun 26, 2026, 21:13 ET Shell aportará 5 millones de dólares en ayuda humanitaria para Venezuela
negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative, judicial, fiscal and regulatory developments including tariffs and regulatory measures addressing climate change; (k) economic and financial
More news about: Shell Oil Company
Jun 26, 2026, 20:45 ET Shell to provide $5 million in disaster relief funding for Venezuela
negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative, judicial, fiscal and regulatory developments including tariffs and regulatory measures addressing climate change; (k) economic and financial
More news about: Shell Oil Company
Jun 26, 2026, 20:40 ET BetterInvesting™ Magazine Update on Deckers Outdoor Corp.(NYSE: DECK) and Euronet Inc. (NYSE: EEFT)
Euronet by viewing their fundamental data and applying judgments.Committee members are Dan Rutter, CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; and Anne Nichols, CFA.As stated, the BetterInvesting committee's Stock to Study and Undervalued
More news about: NAIC-BetterInvesting
Jun 26, 2026, 18:00 ET 57 Greenberg Traurig Attorneys Named to 2026 Florida Super Lawyers and 'Rising Stars' Lists
Norman J. Benford — 20+ years
More news about: Greenberg Traurig, LLP
Jun 26, 2026, 16:00 ET Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
https://www.mayoclinic.org/diseases-conditions/gout/symptoms-causes/syc-20372897. [3] Chen-Xu M, et al. Arthritis Rheumatol. 2019;71(6):991–999. [4] McAdams MA, et al. J Rheumatol. 2011;38(1):135–141.CONTACT: Gerard Tobin Head of Investor Relations
More news about: Swedish Orphan Biovitrum AB
Jun 26, 2026, 15:59 ET Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
https://www.mayoclinic.org/diseases-conditions/gout/symptoms-causes/syc-20372897. [3] Chen-Xu M, et al. Arthritis Rheumatol. 2019;71(6):991–999. [4] McAdams MA, et al. J Rheumatol. 2011;38(1):135–141.CONTACT: Gerard Tobin Head of Investor Relations
More news about: Swedish Orphan Biovitrum AB
Jun 26, 2026, 14:35 ET Revision Skincare® Appoints Marco Ficarelli as Chief Global Growth Officer
professional results by targeting skin longevity at its source. As the only brand formulating specifically for the Dermal‑Epidermal Junction (D•E•J)—known as the Longevity Layer™, Revision Skincare addresses visible signs of aging by strengthening the skin's biological foundation. For more than
More news about: Revision Skincare
Jun 26, 2026, 12:35 ET Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
placebo-controlled phase 3 study. The Lancet Neurology. 2025; 24:105–16.8 Kenneth J, et al. Nipocalimab in Early-onset Severe Hemolytic Disease of the Fetus & Newborn. N Engl J Med. 2024 Aug 8;391(6):526-5379 Noaiseh G, et al. Efficacy and safety of nipocalimab
More news about: Johnson & Johnson
Jun 26, 2026, 11:23 ET Blaize Holdings, Inc. Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses
communication. The attorney responsible for this communication is Frank J. Johnson.Contact:Johnson Fistel, PLLP501 W. Broadway, Suite 800San Diego, CA 92101James Baker, Investor Relations – or – Frank J. Johnson, Esq.(619) 814-4471
More news about: Johnson Fistel, PLLP
Jun 26, 2026, 08:00 ET Ahead of First National Parkinson's Project Advisory Council Meeting, Leading Parkinson's Organizations Call for Urgent Action
www.apdaparkinson.org.About The Michael J. Fox Foundation for Parkinson's ResearchAs the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved
More news about: The Michael J. Fox Foundation for Parkinson's Research
Jun 26, 2026, 07:16 ET Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies. J Hematol Oncol. 2021;14(1):40. Published
More news about: Eli Lilly and Company